EPIM

Evelyn Partners Investment Management Portfolio holdings

AUM $2.42B
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.2B
AUM Growth
–
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
261
New
Increased
Reduced
Closed

Top Buys

1
+$196M
2
+$190M
3
+$157M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$118M
5
V icon
Visa
V
+$110M

Top Sells

No sells this quarter

Sector Composition

1 Technology 21.97%
2 Financials 20.95%
3 Healthcare 16.15%
4 Consumer Discretionary 14.67%
5 Communication Services 11.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTRS icon
226
Viatris
VTRS
$12.1B
$14.6K ﹤0.01%
+1,588
SRE icon
227
Sempra
SRE
$60.5B
$14.3K ﹤0.01%
+338
FTV icon
228
Fortive
FTV
$16.7B
$13.4K ﹤0.01%
+183
DBX icon
229
Dropbox
DBX
$7.92B
$13.4K ﹤0.01%
+6,245
PBR icon
230
Petrobras
PBR
$75.7B
$11.8K ﹤0.01%
+14,910
ONC
231
BeOne Medicines Ltd
ONC
$34.1B
$11.2K ﹤0.01%
+165
HCA icon
232
HCA Healthcare
HCA
$105B
$10.4K ﹤0.01%
+30
ARVN icon
233
Arvinas
ARVN
$676M
$10.3K ﹤0.01%
+346
FICO icon
234
Fair Isaac
FICO
$40B
$9.22K ﹤0.01%
+37
ZBH icon
235
Zimmer Biomet
ZBH
$20.4B
$9.06K ﹤0.01%
+80
NEOG icon
236
Neogen
NEOG
$1.35B
$8.67K ﹤0.01%
+63
ASIX icon
237
AdvanSix
ASIX
$539M
$8.59K ﹤0.01%
+14,897
KD icon
238
Kyndryl
KD
$6.59B
$8.48K ﹤0.01%
+274
SNPS icon
239
Synopsys
SNPS
$86.2B
$8.15K ﹤0.01%
+1,677
TRU icon
240
TransUnion
TRU
$16.6B
$8.13K ﹤0.01%
+98
TMUS icon
241
T-Mobile US
TMUS
$244B
$6.67K ﹤0.01%
+302
IDXX icon
242
Idexx Laboratories
IDXX
$51.3B
$5.04K ﹤0.01%
+12
CDZI icon
243
Cadiz
CDZI
$430M
$4.01K ﹤0.01%
+934
MAT icon
244
Mattel
MAT
$5.94B
$3.89K ﹤0.01%
+178
APLS icon
245
Apellis Pharmaceuticals
APLS
$3.56B
$3.28K ﹤0.01%
+1,377
CC icon
246
Chemours
CC
$2.1B
$2.57K ﹤0.01%
+2,463
TAK icon
247
Takeda Pharmaceutical
TAK
$44.2B
$2.49K ﹤0.01%
+955
SOLV icon
248
Solventum
SOLV
$12.4B
$2.43K ﹤0.01%
+6
GRAL
249
GRAIL Inc
GRAL
$3.22B
$2.09K ﹤0.01%
+1,665
EMBC icon
250
Embecta
EMBC
$838M
$1.46K ﹤0.01%
+128
7 8 9
10
11